CD19-targeted CAR T2 cells
Term · Oncology and biomedicine · MLC-T-ONC-012383
A preparation of T lymphocytes that have been genetically modified to express a chimeric antigen receptor (CAR) targeting the tumor-associated antigen (TAA) CD19, with potential immunostimulating and antineoplastic activities. Upon administration, CD19-targeted CAR T2 cells target and bind to CD19-expressing tumor cells, thereby inducing selective toxicity in CD19-expressing tumor cells. CD19 antigen is a B-cell-specific cell surface antigen expressed in all B-cell lineage malignancies.
| Identifier | MLC-T-ONC-012383 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | CD19-CAR-T2 Cells |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-012383",
"term": "CD19-targeted CAR T2 cells",
"field": "Oncology and biomedicine",
"definition": "A preparation of T lymphocytes that have been genetically modified to express a chimeric antigen receptor (CAR) targeting the tumor-associated antigen (TAA) CD19, with potential immunostimulating and antineoplastic activities. Upon administration, CD19-targeted CAR T2 cells target and bind to CD19-expressing tumor cells, thereby inducing selective toxicity in CD19-expressing tumor cells. CD19 antigen is a B-cell-specific cell surface antigen expressed in all B-cell lineage malignancies.",
"synonyms": [
"CD19-CAR-T2 Cells"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/cd19-targeted-car-t2-cells/"
}
Record 4,397 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.